UBS Oncology Impact Fund L.P. - Insider Trading & Ownership
-
Entity
-
Company
-
Location
-
450 Kendall Street, Cambridge, MA
-
Summary
-
The estimated value of insider holdings of UBS Oncology Impact Fund L.P. is at least $95.3M dollars as of June 5, 2023. UBS Oncology Impact Fund L.P. is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $95.3M.
Ownership of UBS Oncology Impact Fund L.P.
Insider Transactions Reported by UBS Oncology Impact Fund L.P.:
* An asterisk sign (*) next to the price indicates that the price is likely invalid.